Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization
about
Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypesNanomedicine approaches for corneal diseasesProgress in corneal wound healingTopical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal NeovascularizationTargeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.Nanoengineering of therapeutics for retinal vascular disease.Nanotechnology in corneal neovascularization therapy--a reviewPreparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.Nanotechnology approaches for ocular drug delivery.Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.Gene therapy in corneal transplantation.Dendrimers for gene delivery--a potential approach for ocular therapy?Stem Cell Therapy for Corneal Regeneration Medicine and Contemporary Nanomedicine for Corneal Disorders.Polymeric nanoparticles: the future of nanomedicine.Subconjunctival injection of antagomir-21 alleviates corneal neovascularization in a mouse model of alkali-burned cornea.Targeting herpetic keratitis by gene therapy.Reducible Polyethylenimine Nanoparticles for Efficient siRNA Delivery in Corneal Neovascularization Therapy.Curcumin nanoparticles inhibit corneal neovascularization.
P2860
Q26830537-04E2F004-DFF2-42CF-B0AB-95AC70891575Q27022253-7B1110A3-12BD-45A4-B830-05DF290639D8Q28081311-359C3DCB-6FC3-4AF6-B0BD-DB149E2333BBQ28831101-9A6F9809-297A-445B-9667-5415259EBF0DQ30539153-219A9050-EC3A-4752-AAE0-6B9CCF4D705CQ35645705-C894DF97-0727-401F-B900-E1D9E365CA9EQ36696450-B38A14FA-F99B-49B6-85DF-B841C252B335Q37573788-66F5D263-EE3A-47B0-AA01-0D63284F8AAFQ38098509-379CB6F7-2725-4DE9-AA02-F62B2F8082D6Q38100561-48446E92-3E08-4850-8ED5-3422C4E652DBQ38128390-2DD47825-A06D-48D4-9B46-FA1957C0C08FQ38153722-EE8C581F-749D-43CC-B34F-A917A4471401Q38196447-B5006BE5-EE79-422D-B615-6C8295FC822EQ38288519-5189C6D8-9768-4F94-8171-FF503A1C80F1Q38575282-F240386A-E268-4565-906F-CE10C805037EQ39041180-22711AC2-77F9-40B2-9F9A-4EEE5F857E71Q41951959-AF84554E-DC34-45BA-A72A-49B5C3D6FFA0Q47610066-7ED3ACF2-B663-4B02-88CB-2E03A5C900DDQ53543456-34130533-F0EC-4AEB-98AB-814A5103635F
P2860
Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nanoparticle-mediated delivery ...... ses corneal neovascularization
@ast
Nanoparticle-mediated delivery ...... ses corneal neovascularization
@en
type
label
Nanoparticle-mediated delivery ...... ses corneal neovascularization
@ast
Nanoparticle-mediated delivery ...... ses corneal neovascularization
@en
prefLabel
Nanoparticle-mediated delivery ...... ses corneal neovascularization
@ast
Nanoparticle-mediated delivery ...... ses corneal neovascularization
@en
P2093
P2860
P356
P1476
Nanoparticle-mediated delivery ...... ses corneal neovascularization
@en
P2093
Balamurali K Ambati
Brian Stagg
Jacquelyn Simonis
Nirbhai Singh
Swita Singh
Uday B Kompella
Xiaohui Zhang
Yureeda Qazi
P2860
P304
P356
10.1167/IOVS.11-9139
P407
P577
2012-05-14T00:00:00Z